Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
#Protein Engineering Market Size And Revenue Forecast Through 2030
The protein engineering market has witnessed rapid expansion over recent years. It is anticipated to grow from $4.62 billion in 2025 to $5.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The historical development of this market is attributable to the proliferation of biopharmaceutical research activities, the greater availability of sophisticated laboratory instruments, an increase in academic protein research, rising capital allocations in biotechnology, and advancements in protein characterization techniques.
The protein engineering market is set for significant expansion over the next few years. It is projected to achieve a valuation of $9.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This projected growth is largely due to factors such as a heightened demand for advanced biologics, the ongoing growth of personalized medicine, the increasing utilization of engineered proteins in vaccine production, a surge in the adoption of computational biology, and expanded collaborative efforts between industry and academic sectors. Notable trends during this period are expected to include a wider acceptance of rational protein design methods, an increased application of AI in protein modeling, a rising need for engineered therapeutic proteins, the expansion of bespoke protein engineering services, and a more robust integration of bioinformatics tools.
Download A Free Sample Report For Comprehensive Market Insights:
Protein Engineering Market Expansion Supported By Key Demand Factors
The growing requirement for protein-based medications is fueling the protein engineering market. Protein-based drugs, often referred to as therapeutic proteins, are medicines that utilize proteins for their healing capabilities and are essentially genetically modified versions of human proteins naturally present in the body. Protein engineering involves modifying protein sequences by substituting, inserting, or deleting nucleotides within their encoding genes to develop protein-based drugs optimized for specific applications. For example, a study from the Lancet Diabetes and Endocrinology journal projects that nearly 80 million individuals with type-2 diabetes will require insulin by 2030, representing a 20% increase. Therefore, the expanding demand for protein-based drugs is a key driver for the protein engineering market.
Protein Engineering Market Segment Performance And Strategic Opportunities
The protein engineering market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents, Services And Software
2) By Technology: Irrational Protein Design, Rational Protein Design
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations
Subsegments:
1) By Instruments: Protein Purification Systems, Spectroscopy And Imaging Systems, Mass Spectrometers
2) By Reagents: Enzymes, Antibodies, Labeling And Detection Reagents
3) By Services And Software: Custom Protein Engineering Services, Analytical Services, Consulting Services, Modeling And Simulation Software, Data Analysis Software, Bioinformatics Tools
Protein Engineering Market Growth Trends Influencing Competitive Dynamics
Companies leading in the protein engineering market are developing inventive products featuring advanced technologies like the SUREtechnology platform to improve the stability, effectiveness, and production ease of therapeutic proteins. This platform facilitates exact modifications, which enables the creation of next-generation biologics that possess better therapeutic characteristics, fewer side effects, and increased manufacturing efficiency. For example, KBI Biopharma, a US-based biotechnology company, introduced SUREmAb in September 2023, a novel offering developed on its SUREtechnology platform. This product aims for optimized, safe, and cost-efficient monoclonal antibody (mAb) development and manufacturing, responding to the rising demand for biopharmaceuticals. SUREmAb supports swift progress from transfection to Research Cell Bank (RCB) in as little as 9 weeks and allows for drug substance release within 11 months.
Protein Engineering Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the protein engineering market are Codexis Inc., GenScript Biotech Corporation, Abzena plc, Aragen Bioscience Inc., Enantis s.r.o., Creative BioMart, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Amyris Inc., Absci Corporation, Generate Biomedicines Inc., ProteinQure Inc., Zymeworks Inc., Adimab LLC, Ichnos Sciences SA, Synthego Corporation, Evotec SE, Pieris Pharmaceuticals Inc., MacroGenics Inc., Adagene Inc.
Access The Complete Protein Engineering Market Report:
Protein Engineering Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the protein engineering market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.